Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Neurocrine Biosciences (NBIX) Gross Profit (2017 - 2026)

Neurocrine Biosciences filings provide 9 years of Gross Profit readings, the most recent being $787.9 million for Q4 2025.

  • On a quarterly basis, Gross Profit rose 27.41% to $787.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.8 billion, a 20.98% increase, with the full-year FY2025 number at $2.8 billion, up 20.98% from a year prior.
  • Gross Profit hit $787.9 million in Q4 2025 for Neurocrine Biosciences, up from $780.9 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $787.9 million in Q4 2025 to a low of $15.2 million in Q2 2022.
  • Median Gross Profit over the past 5 years was $464.4 million (2023), compared with a mean of $460.2 million.
  • Biggest five-year swings in Gross Profit: crashed 94.68% in 2022 and later skyrocketed 2802.63% in 2023.
  • Neurocrine Biosciences' Gross Profit stood at $307.9 million in 2021, then surged by 31.31% to $404.3 million in 2022, then rose by 25.33% to $506.7 million in 2023, then grew by 22.04% to $618.4 million in 2024, then grew by 27.41% to $787.9 million in 2025.
  • The last three reported values for Gross Profit were $787.9 million (Q4 2025), $780.9 million (Q3 2025), and $676.2 million (Q2 2025) per Business Quant data.